Clinical Trials Logo
  1. Home
  2. Lymphopenia
  3. NCT02698683

Lymphocyte Count as a Sign of Immunoparalysis and Its Correlation With Nutritional Status in Septic Pediatric Patients

Lymphopenia Clinical Trial

Official title:
Lymphocyte Count as a Sign of Immunoparalysis and Its Correlation With Nutritional Status in Septic Pediatric Intensive Care Patients: A Pilot Study

Clinical Trial Summary

Participants were classified as normal or malnourished according to anthropometric measures. Serum albumin and zinc were recovered on the 1st and 7th days of hospitalization. Lymphocyte count was also recorded on the 1st and 7th days.

Clinical Trial Description

The investigators enrolled 14 consecutive patients with sepsis. Patients were classified as normal or malnourished according to anthropometric measures. As an additional evaluation of nutritional status, serum albumin and zinc were recovered on the 1st and 7th days of hospitalization. Lymphocyte count was also recorded on the 1st and 7th days. Investigators correlated nutritional status with lymphocyte count and zinc dosage. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02698683
Study type Observational
Source University of Sao Paulo
Contact
Status Completed
Phase N/A
Start date February 2014
Completion date January 2016
View Details
See also
  Status Clinical Trial Phase
Terminated NCT02659800 - Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas Phase 1
Completed NCT00771810 - Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer Phase 2
Completed NCT00477321 - Safety Study of IL-7 in HIV-infected Patients (Inspire) Phase 1
Completed NCT06368349 - Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma
Completed NCT04910230 - Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19 N/A
Completed NCT04800731 - Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19
Completed NCT04404608 - Etiology of Lymphopenia in Covid19 Infection
Recruiting NCT06181656 - Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation
Completed NCT05889169 - Stroke-induced Immunodepression in Neurorehabilitation
Withdrawn NCT01660347 - Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant N/A